Table 1 Criteria currently in use to define metabolic health
| Â | NCEP-ATPIII [ 10] | Wildman et al. [11] | Doumatey et al. [12] | Hamer et al. [13] | Aguilar-Salinas et al. [14] | Lynch et al. [15] | Karelis et al. [16] | Harmonisation criteria (Lavie et al.) [17] |
|---|---|---|---|---|---|---|---|---|
BP (mmHg) | SBP ≥ 130 or DBP ≥ 85 or on Rx | SBP ≥ 130or DBP ≥ 85 or on Rx | SBP > 130or DBP > 85 or not on Rx | SBP ≥ 130 or DBP ≥ 85 or on Rx | SBP ≥ 140 or DBP < 90 or not on Rx | SBP > 130or DBP > 85 & not on Rx |  | SBP ≥ 130 or DBP ≥ 85 or on Rx |
TG (mmol/L) | ≥1.69 mmol/L | ≥ 1.70 |  |  |  |  | ≥1.70 | ≥ 1.70 |
HDL-C (mmol/L) | HDL-C < 1.03 mmol/L in men or < 1.29 mmol/L in women or on Rx | <1.04 in men or < 1.30 on women | <1.03 in men or < 1.29 in women | <1.03 in men or < 1.30 in women | < 1.00 |  | <1.30 & not on Rx | <1.0 in men or < 1.30 in women |
TG/HDL ratio |  |  |  |  |  | >1.65 in men or > 1.32 in women & not on Rx |  |  |
LDL-C (mmol/L) |  |  |  |  |  |  | ≥2.60 |  |
T. Chol (mmol/L) |  |  |  |  |  |  | ≥5.20 |  |
FPG (mmol/L) | ≥ 5.6 or on Rx | ≥ 5.55 or on Rx | ≤7.0 | Presence of diabetes | ≥7.0 or on Rx |  |  | ≥ 5.6 or on Rx |
WC (cm) | >102 in men and > 88 in women |  |  | >102 in men or > 88 in women |  |  |  |  |
HOMA-IR | Â | >5.13 | Â | Â | Â | Â | <1.95 | Â |
hsCRP (ng/L) | Â | >0.1 | Â | >3.0 | Â | Â | Â | Â |
No. of criteria required to characterize the metabolically healthy phenotype | 0, ≤ 1 or ≤ 2 | <2 of the above | None of the above | < 2 of the above | None of the above | None of the above | ≤ 1 of the above | None of the above |